Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose

International Immunology

Volumn 11, Issue 2, 1999, Pages 151-158

  Yoshida, Shin Ichi ^a   Kato, Tetsuji ^a   Sakurada, Shinsaku ^a   Kurono, Chieko ^a   Yang, Jian Ping ^a   Matsui, Nobuo ^a   Soji, Tsuyoshi ^a   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Electron microscopy; NF B; Redox regulation

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOGLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; CLINICAL ARTICLE; DNA BINDING; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSMISSION ELECTRON MICROSCOPY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUROTHIOGLUCOSE; CELLS, CULTURED; FIBROBLASTS; GOLD COMPOUNDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MICROSCOPY, ELECTRON; NF-KAPPA B; RHODAMINES; STAINING AND LABELING; SYNOVIAL MEMBRANE;

EID: 0033048351     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.2.151     Document Type: Article

References (36)

1. Mukaida, N., Mahe, Y. and Matsushima, K. 1990. Cooperative interaction of nuclear factor-kappa B and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:21128.
2. Schreck, R. and Baeuerle, P. A. 1990. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 10:1281.
3. Libermann, T. A. and Baltimore, D. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:2327.
4. Sakurada, S., Kato, T. and Okamoto, T. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int. Immunol. 8:1483.
5. Handel, M. L., McMorrow, L. B. and Gravallese, E. M. 1995. Nuclear factor-κB in rheumatoid synovium. Arthritis Rheum. 38:1762.
6. Marok, R., Winyard, P. G., Coumbe, A., Kus, M. L., Gaffney, K., Blades, S., Mapp, P. I., Morris, C. J., Blake, D. R., Kaltschmidt, C. and Baeurle, P. A. 1996. Activation of the transcriptional factor nuclear factor-κB in human inflamed synovial tissue. Arthritis Rheum. 39:583.
7. Forestier, J. 1934. Rheumatoid arthritis and its treatment by gold salts. Lancet 227:646.
8. Loetscher, P., Dewald, B., Baggiolini, M. and Seitz, M. 1994. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 6:162.
9. Yang, J. P., Merin, J. P., Nakano, T., Kato, T., Kitade, Y. and Okamoto, T. 1995. Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett. 361:89.
10. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liaang, M. H., Luthra, H. S., Medsger, T. A., Mitchell, D. M., Neustadt, D. H., Pinals, R. S., Schaller, J. G., Sharp, J. T., Wilder, R. L. and Hunder, G. G. 1987. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
11. Hayashi, T., Ueno, Y. and Okamoto, T. 1993. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380.
12. Okamoto, T., Ogiwara, H., Hayashi, T., Mitsui, A., Kawabe, T. and Yodoi, J. 1992. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4:811.
13. Okamoto, K. and Utamura, M. 1938. Biologische untersuchungen des Goldes. 1 Mitteilung uber die histochemische Gold nachweismethode. Acta Scholae. Med. Kioto. 22:373.
14. Luft, J. H. 1961. Improvement in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9:409.
15. Ghadially, F. N., Oryshak, A. F. and Mitchel, I D. M. 1976. Ultrastructural changes produced in rheumatoid synovial membrane by chrysotherapy. Ann. Rheum. Dis. 35:67.
16. Nakamura, H. and Igarashi, M. 1977 Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate. Studies by electron microscope and electron probe X-ray microanalysis. Ann. Rheum. Dis. 36:209.
17. Madhok, R., Crilly, A., Murphy, E., Smith, J., Watson, J. and Capell, H. A. 1993. Gold therapy lowers serum interleukin 6 levels in rheumatoid arthritis. J. Rheumatol. 20:630.
18. Yanni, G., Nabil, M., Farahat, M. R., Poston, R. N. and Panayi, G. S. 1994. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann. Rheum. Dis. 53:315.
19. Crilly, A., Madhok, R., Watson, J., Capell, H. A. and Sturrock, R. D. 1994. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy. Br. J. Rheumatol. 33:821.
20. Seitz, M., Dewald, B., Ceska, M., Gerber, N. and Baggiolini, M. 1992. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol. Int. 12:159.
21. Deleuran, B., Kristensen, M., Paludan, K., Zachariae, C., Larsen, C. G., Zachariae, E. and Thestrup-Pedersen, K. 1992. The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells. Cytokine 4:403.
22. Situnayake, R. D. and McConkey, B. 1990. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response. J. Rheumatol. 17:1268.
23. Conaghan, P. G. and Brooks, P. 1995. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine [Review]. Curr. Opin. Rheumatol. 7:167.
24. Bento, R. M., Jose, L. G. and Richard, H. F. 1972. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds - reinvestigated. Arthritis Rheum. 15:391.
25. Okamoto, T., Sakurada, S., Yang, J. P., and Merin, J. P. 1997. Regulation of NF-κB and Disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr. Topics Cell Reg. 35:149.
26. Williams, D. H., Jeffery, L. J. and Murray, E. J. 1992. Aurothioglucose inhibits induced NF-κB and AP-1 activity by acting as an IL-1 functional antagonist. Biochim. Biophys. Acta. 1180:9.
27. Miyatake, S., Shlomai, J., Arai, K. and Arai, N. 1991. Characterization of the mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) gene promoter: nuclear factors that interact with an element shared by three lymphokine genes - those for GM-CSF, interleukin-4 (IL-4), and IL-5. Mol. Cell. Biol. 11:5894.
28. Staynov, D. Z., Cousins, D. J. and Lee, T. H. 1995. A regulatory element in the promoter of the human granulocyte-macrophage colony-stimulating factor gene that has related sequences in other T-cell-expressed cytokine genes. Proc. Natl Acad. Sci. USA 92:3606.
29. Traber, K. E., Okamoto, H., Kurono, C., Baba, M., Saliou, C., Soji, T., Packer, L. and Okamoto, T. 1999. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int. Immunol. 11:143.
30. Merin, J. P., Matsuyama, M., Kira, T., Baba, M. and Okamoto, T. 1996. α-Lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants. FEBS Lett. 394:9.
31. Kopp, E. and Ghosh, S. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956.
32. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, J. A. S. 1994. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283.
33. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286.
34. Beg, A. A. and Baltimore, D. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
35. Wang, C. Y., Mayo, M. W. and Baldwin, A. S., Jr. 1996. TNF-and cancer therapy-induced apoptosis: protection by inhibition of NF-κB. Science 274:784.
36. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H. and Sonenshein, G. E. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682.